Cargando…

Injection drug induced septic embolism—A growing concern

Septic pulmonary embolism is an obstruction of the pulmonary vasculature due to embolization of an infected thrombus. In many instances, the etiology is cardiac in origin, given the increased prevalence of intravenous drug users in the United States. This condition usually presents with fever, chest...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelson, Michael, Chaudhry, Asaad, Nguyen, Andrew, Girgis, Sameh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520423/
https://www.ncbi.nlm.nih.gov/pubmed/36188073
http://dx.doi.org/10.1016/j.radcr.2022.08.057
_version_ 1784799624512405504
author Kelson, Michael
Chaudhry, Asaad
Nguyen, Andrew
Girgis, Sameh
author_facet Kelson, Michael
Chaudhry, Asaad
Nguyen, Andrew
Girgis, Sameh
author_sort Kelson, Michael
collection PubMed
description Septic pulmonary embolism is an obstruction of the pulmonary vasculature due to embolization of an infected thrombus. In many instances, the etiology is cardiac in origin, given the increased prevalence of intravenous drug users in the United States. This condition usually presents with fever, chest pain, dyspnea, and cough. In order to make the diagnosis, it is helpful to utilize tools like the modified Duke criteria when evaluating for infective endocarditis in the context of pulmonary emboli and septic shock. The gold standard method for establishing the diagnosis of this condition involves imaging modalities, including echocardiogram and computed tomography findings. This case report details a 36-year-old male with a history of drug abuse and hepatitis C, who was found to have an isolated vegetation on the pulmonic valve and septic pulmonary embolism. The patient experienced a rapidly deteriorating clinical course, however improved over the course of 2 weeks with supportive measures and appropriate antibiotic treatment. The purpose of this case report is to highlight the uncommon nature of pulmonary valve involvement in patients with infective endocarditis. Moreover, the goal of this report is to recognize the paralleled increase in septic pulmonary emboli with the rising incidence of patients using injectable opioids in the United States.
format Online
Article
Text
id pubmed-9520423
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95204232022-09-30 Injection drug induced septic embolism—A growing concern Kelson, Michael Chaudhry, Asaad Nguyen, Andrew Girgis, Sameh Radiol Case Rep Case Report Septic pulmonary embolism is an obstruction of the pulmonary vasculature due to embolization of an infected thrombus. In many instances, the etiology is cardiac in origin, given the increased prevalence of intravenous drug users in the United States. This condition usually presents with fever, chest pain, dyspnea, and cough. In order to make the diagnosis, it is helpful to utilize tools like the modified Duke criteria when evaluating for infective endocarditis in the context of pulmonary emboli and septic shock. The gold standard method for establishing the diagnosis of this condition involves imaging modalities, including echocardiogram and computed tomography findings. This case report details a 36-year-old male with a history of drug abuse and hepatitis C, who was found to have an isolated vegetation on the pulmonic valve and septic pulmonary embolism. The patient experienced a rapidly deteriorating clinical course, however improved over the course of 2 weeks with supportive measures and appropriate antibiotic treatment. The purpose of this case report is to highlight the uncommon nature of pulmonary valve involvement in patients with infective endocarditis. Moreover, the goal of this report is to recognize the paralleled increase in septic pulmonary emboli with the rising incidence of patients using injectable opioids in the United States. Elsevier 2022-09-15 /pmc/articles/PMC9520423/ /pubmed/36188073 http://dx.doi.org/10.1016/j.radcr.2022.08.057 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Kelson, Michael
Chaudhry, Asaad
Nguyen, Andrew
Girgis, Sameh
Injection drug induced septic embolism—A growing concern
title Injection drug induced septic embolism—A growing concern
title_full Injection drug induced septic embolism—A growing concern
title_fullStr Injection drug induced septic embolism—A growing concern
title_full_unstemmed Injection drug induced septic embolism—A growing concern
title_short Injection drug induced septic embolism—A growing concern
title_sort injection drug induced septic embolism—a growing concern
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520423/
https://www.ncbi.nlm.nih.gov/pubmed/36188073
http://dx.doi.org/10.1016/j.radcr.2022.08.057
work_keys_str_mv AT kelsonmichael injectiondruginducedsepticembolismagrowingconcern
AT chaudhryasaad injectiondruginducedsepticembolismagrowingconcern
AT nguyenandrew injectiondruginducedsepticembolismagrowingconcern
AT girgissameh injectiondruginducedsepticembolismagrowingconcern